<!DOCTYPE html>
<html>
<head>
  <title>Onkobioloogia</title>
  <meta charset="utf-8">
  <meta name="description" content="Onkobioloogia">
  <meta name="author" content="Taavi Päll">
  <meta name="generator" content="slidify" />
  <meta name="apple-mobile-web-app-capable" content="yes">
  <meta http-equiv="X-UA-Compatible" content="chrome=1">
  <link rel="stylesheet" href="libraries/frameworks/io2012/css/default.css" media="all" >
  <link rel="stylesheet" href="libraries/frameworks/io2012/css/phone.css" 
    media="only screen and (max-device-width: 480px)" >
  <link rel="stylesheet" href="libraries/frameworks/io2012/css/slidify.css" >
  <link rel="stylesheet" href="libraries/highlighters/highlight.js/css/tomorrow.css" />
  <base target="_blank"> <!-- This amazingness opens all links in a new tab. -->  
  
  <!-- Grab CDN jQuery, fall back to local if offline -->
  <script src="http://ajax.aspnetcdn.com/ajax/jQuery/jquery-1.7.min.js"></script>
  <script>window.jQuery || document.write('<script src="libraries/widgets/quiz/js/jquery.js"><\/script>')</script> 
  <script data-main="libraries/frameworks/io2012/js/slides" 
    src="libraries/frameworks/io2012/js/require-1.0.8.min.js">
  </script>
  
  

</head>
<body style="opacity: 0">
  <slides class="layout-widescreen">
    
    <!-- LOGO SLIDE -->
        <slide class="title-slide segue nobackground">
  <hgroup class="auto-fadein">
    <h1>Onkobioloogia</h1>
    <h2>Vähitüübid</h2>
    <p>Taavi Päll<br/>lektor, Tallinna Tehnikaülikool</p>
  </hgroup>
  <article></article>  
</slide>
    

    <!-- SLIDES -->
    <slide class="" id="slide-1" style="background:;">
  <article data-timings="">
    <!-- Limit image width and height -->

<style type="text/css">
img {     
  max-height: 480px;     
  max-width: 800px; 
}
</style>

<style> .title-slide {
  background-image:url(http://www.newcomersupply.com/media/gallery/3830-colon-ca-40x-p1-captions.jpg); 
  background-repeat: no-repeat; 
  background-position: 20% 5%; 
  background-size: 46%; 
  background-color: #CBE7A5; /* ; ; */ }
  background-color: #FFFFFF; /*#CBE7A5 #EDE0CF; ; #CA9F9D*/
}

.title-slide hgroup > h1{
 font-family: 'Oswald', 'Helvetica', sanserif; 
}

.title-slide hgroup > h1, 
.title-slide hgroup > h2 {
  color: #535E43 ;  /* ; #EF5150*/
}
</style>

<style>
strong {
  font-weight: bold;
}
</style>

<!-- Center image on slide -->

<script type="text/javascript" src="http://ajax.aspnetcdn.com/ajax/jQuery/jquery-1.7.min.js"></script>

<script type="text/javascript">
$(function() {     
  $("p:has(img)").addClass('centered'); 
});
</script>

  </article>
  <!-- Presenter Notes -->
</slide>

<slide class="segue dark nobackground" id="slide-2" style="background:;">
  <hgroup>
    <h2>Ajaloost</h2>
  </hgroup>
  <article data-timings="">
    
  </article>
  <!-- Presenter Notes -->
</slide>

<slide class="" id="slide-3" style="background:;">
  <hgroup>
    <h2>Egiptus, 16-17. dünastia</h2>
  </hgroup>
  <article data-timings="">
    
<div style='float:left;width:48%;' class='centered'>
  <ul>
<li>Vanim teadaolev kirjeldus vähist pärineb 1500 BC Egiptusest. </li>
<li>Papüürus kirjeldab muuseas ka 8 rinnavähi juhtu mida raviti põletusega. </li>
<li>Kirjutises konstanteeritakse et see haigus on ravimatu.</li>
</ul>

</div>
<div style='float:right;width:48%;'>
  <p><img src="https://upload.wikimedia.org/wikipedia/commons/thumb/b/b4/Edwin_Smith_Papyrus_v2.jpg/1280px-Edwin_Smith_Papyrus_v2.jpg" style="width:420px"></p>

<p><footer class="source">Allikas: Wikipedia. Pilt: &quot;Edwin Smith Papyrus v2&quot; by Jeff Dahl
</footer></p>

</div>
  </article>
  <!-- Presenter Notes -->
</slide>

<slide class="" id="slide-4" style="background:;">
  <hgroup>
    <h2>Kasvajad kui tulnukad</h2>
  </hgroup>
  <article data-timings="">
    <ul>
<li>Hippokrates: vähi &quot;kehavedelike tasakaalu häire teooria&quot; (must-, kollane sapp, veri ja flegma) </li>
<li>vähke ajalooliselt käsitletud ka kui võõrkeha, mis on ennast haige kehas sisse seadnud.</li>
</ul>

<p><img src="http://images.medicaldaily.com/sites/medicaldaily.com/files/styles/full_breakpoints_theme_medicaldaily_desktop_1x/public/2015/06/24/tumor-removed.jpg" style="width:300px"></p>

<p><footer class="source">Pilt: Vähi kirurgiline eemaldamine, 1689. Wikimedia.
</footer></p>

  </article>
  <!-- Presenter Notes -->
</slide>

<slide class="" id="slide-5" style="background:;">
  <hgroup>
    <h2>Kasvajad on koelise struktuuriga</h2>
  </hgroup>
  <article data-timings="">
    
<div style='float:left;width:48%;' class='centered'>
  <ul>
<li>1655. avastas Robert Hooke mikroskoopi kasutades, et taimekude koosneb rakkudest. </li>
<li>Seoses mikroskoopia arenguga 19. saj. saadi aru, 

<ul>
<li>kasvajad koosnevad rakkudest </li>
<li>pärinevad normaalsetest kudedest</li>
</ul></li>
</ul>

</div>
<div style='float:right;width:48%;'>
  <p><img src="https://encrypted-tbn1.gstatic.com/images?q=tbn:ANd9GcRJfwOppv_7oHAerDTw5UqxeJwsVWOkXH_DS2wIdaA98B7QWn36" alt="microscopist"></p>

<p><footer class="source">Pilt: internet.
</footer></p>

</div>
  </article>
  <!-- Presenter Notes -->
</slide>

<slide class="" id="slide-6" style="background:;">
  <hgroup>
    <h2>Vähki põhjustavad kartsinogeenid</h2>
  </hgroup>
  <article data-timings="">
    
<div style='float:left;width:48%;' class='centered'>
  <ul>
<li>1775. a. identifitseeris kirurg sir Percivall Pott korstnapühkijatel nõe ja munandikasvajate vahelise seose - keskkonnas leiduvad kartsinogeenid võivad põhjustada vähki.</li>
</ul>

</div>
<div style='float:right;width:48%;'>
  <p><img src="http://images.medicaldaily.com/sites/medicaldaily.com/files/styles/full_breakpoints_theme_medicaldaily_desktop_1x/public/2015/06/24/chimney-sweeps.JPG" style="width:400px"></p>

<p><footer class="source">Pilt: Korstnapühkijad, hilised 1800-ndad. Wikimedia.
</footer></p>

</div>
  </article>
  <!-- Presenter Notes -->
</slide>

<slide class="segue dark nobackground" id="slide-7" style="background:;">
  <hgroup>
    <h2>Vähitüübid</h2>
  </hgroup>
  <article data-timings="">
    
  </article>
  <!-- Presenter Notes -->
</slide>

<slide class="" id="slide-8" style="background:;">
  <hgroup>
    <h2>Kliiniline klassifikatsioon</h2>
  </hgroup>
  <article data-timings="">
    <p>Kliiniliselt võib kasvajad jaotada kaheks</p>

<ul>
<li>healoomulised (lokaliseerunud, mitteinvasiivsed)</li>
<li>pahaloomulised (invasiivsed, metastaatilised)</li>
</ul>

<p>Metastaasid ehk vähi siirded vastutavad lõviosa kasvajatest tingitud surmade eest!</p>

<ul>
<li>TNM-klassifikatsioon</li>
</ul>

<p><img src="http://3.bp.blogspot.com/_ZWqgYBROGHw/TSGZUB-5SXI/AAAAAAAACGw/sqHnGZR0jJo/s1600/eos.bmp" style="width:300px"></p>

<p><footer class="source">Pilt: doctorsgates.blogspot.com
</footer></p>

  </article>
  <!-- Presenter Notes -->
</slide>

<slide class="" id="slide-9" style="background:;">
  <hgroup>
    <h2>Neli põhilist vähitüüpi</h2>
  </hgroup>
  <article data-timings="">
    <table><thead>
<tr>
<th>Epiteliaalsed</th>
<th>Mitte-epiteliaalsed</th>
</tr>
</thead><tbody>
<tr>
<td>kartsinoomid (<em>carcinoma</em>)</td>
<td>sarkoomid (<em>sarcoma</em>)</td>
</tr>
<tr>
<td></td>
<td>hematopoieetilised</td>
</tr>
<tr>
<td></td>
<td>neuroektodermaaltuumorid</td>
</tr>
</tbody></table>

  </article>
  <!-- Presenter Notes -->
</slide>

<slide class="" id="slide-10" style="background:;">
  <hgroup>
    <h2>Epiteel</h2>
  </hgroup>
  <article data-timings="">
    <p>Kehaosi väljast ja õõsi seest kattev rakukiht (katteepiteel) või näärmeid moodustav rakukogum (näärmeepiteel).</p>

<p><img src="http://medicine2.keele.ac.uk/anatomy/histologyimages/t10.jpg" alt="lamerakk">
<img src="http://medicine2.keele.ac.uk/anatomy/histologyimages/t8.jpg" alt="naarmeepiteel"></p>

<p><footer class="source"><a href="http://medicine2.keele.ac.uk/anatomy/histologyimages/epith.html">Pildid: medicine2.keele.ac.uk</a></footer></p>

  </article>
  <!-- Presenter Notes -->
</slide>

<slide class="" id="slide-11" style="background:;">
  <hgroup>
    <h2>Basaalmembraan</h2>
  </hgroup>
  <article data-timings="">
    
<div style='float:left;width:48%;' class='centered'>
  <p><img src="http://media-2.web.britannica.com/eb-media/63/45063-004-1E7E5B58.jpg" alt="BM"></p>

<p><footer class="source"><a href="http://www.britannica.com/EBchecked/media/37634/Scanning-electron-micrograph-of-basal-lamina-in-the-cornea-of">Pilt: Robert Trelstad</a></footer></p>

</div>
<div style='float:right;width:48%;'>
  <p>BM (basement membrane) on epiteeli all asuv rakuvälise maatriksi kiht</p>

<ul>
<li>peamiseks funktsiooniks on epiteeli ankurdamine all olevale sidekoele (strooma)</li>
<li>mehhaaniline barjäär</li>
</ul>

</div>
  </article>
  <!-- Presenter Notes -->
</slide>

<slide class="" id="slide-12" style="background:;">
  <hgroup>
    <h2>Kartsinoomid</h2>
  </hgroup>
  <article data-timings="">
    <p>Kartsinoomid on kõige sagedasemad epiteliaalset päritolu kasvajad </p>

<ul>
<li>vastutavad 80% vähisurmade eest</li>
</ul>

  </article>
  <!-- Presenter Notes -->
</slide>

<slide class="" id="slide-13" style="background:;">
  <hgroup>
    <h2>Epiteelid pärinevad erinevatest lootelehtedest</h2>
  </hgroup>
  <article data-timings="">
    <ul>
<li>kops, maks, sapipõis, söögitoru, magu ja soolestik pärineb <strong>endodermist</strong> </li>
<li>nahk <strong>ektodermist</strong></li>
<li>munasarjad <strong>mesodermist</strong></li>
</ul>

  </article>
  <!-- Presenter Notes -->
</slide>

<slide class="" id="slide-14" style="background:;">
  <hgroup>
    <h2>Kartsinoomid jagunevad laias laastus kaheks</h2>
  </hgroup>
  <article data-timings="">
    <ul>
<li><strong>adenokartsinoomid</strong> (<em>adenocarcinoma</em>)</li>
<li><strong>lamerakk-kartsinoomid</strong> (<em>squamous-cell carcinoma</em>)</li>
</ul>

  </article>
  <!-- Presenter Notes -->
</slide>

<slide class="" id="slide-15" style="background:;">
  <hgroup>
    <h2>Kartsinoomide sagedasemad paikmed</h2>
  </hgroup>
  <article data-timings="">
    <table><thead>
<tr>
<th><strong>Adeno</strong></th>
<th><strong>Lame-rakk</strong></th>
<th><strong>Muud tüüpi</strong></th>
</tr>
</thead><tbody>
<tr>
<td>kops</td>
<td>nahk</td>
<td>väikeserakuline kopsuvähk (neuroendokriinsed rakud)</td>
</tr>
<tr>
<td>käärsool (<em>colon</em>)</td>
<td>ninaõõs</td>
<td>suurerakuline kopsuvähk</td>
</tr>
<tr>
<td>rind</td>
<td>neel (<em>oropharynx</em>)</td>
<td>maksakartsinoom</td>
</tr>
<tr>
<td>kõhunääre (<em>pancreas</em>)</td>
<td>kõri</td>
<td>neerukasvaja</td>
</tr>
<tr>
<td>magu</td>
<td>kops</td>
<td>transitoorse epiteeli kasvaja (kusepõis)</td>
</tr>
<tr>
<td>söögitoru</td>
<td>söögitoru</td>
<td></td>
</tr>
<tr>
<td>eesnääre</td>
<td>emakakael</td>
<td></td>
</tr>
<tr>
<td>emaka sisemine limaskest (endomeetrium)</td>
<td></td>
<td></td>
</tr>
<tr>
<td>munasari</td>
<td></td>
<td></td>
</tr>
</tbody></table>

  </article>
  <!-- Presenter Notes -->
</slide>

<slide class="" id="slide-16" style="background:;">
  <hgroup>
    <h2>Mitte-epiteliaalsed kasvajad</h2>
  </hgroup>
  <article data-timings="">
    <ul>
<li><strong>sarkoomid</strong> - sidekoekasvajad </li>
<li>hematopieetilist päritolu kasvajad (valged verelibled)

<ul>
<li><strong>leukeemiad</strong> - nn. verevähk</li>
<li><strong>lümfoomid</strong> - tahked kasvajad lümfisõlmedes (B- ja T-rakud)</li>
</ul></li>
<li><strong>neuroektodermaaltuumorid</strong></li>
</ul>

  </article>
  <!-- Presenter Notes -->
</slide>

<slide class="" id="slide-17" style="background:;">
  <hgroup>
    <h2>Sarkoomid</h2>
  </hgroup>
  <article data-timings="">
    
<div style='float:left;width:48%;' class='centered'>
  <ul>
<li>sidekoe kasvajad</li>
<li>moodustavad ~1% vähkidest</li>
<li>mesodermaalset päritolu</li>
</ul>

</div>
<div style='float:right;width:48%;'>
  <table><thead>
<tr>
<th>Sagedasemad sarkoomid</th>
</tr>
</thead><tbody>
<tr>
<td><strong>osteo</strong>sarkoom</td>
</tr>
<tr>
<td><strong>lipo</strong>sarkoom</td>
</tr>
<tr>
<td><strong>leiomüo</strong>sarkoom</td>
</tr>
<tr>
<td><strong>rhabdomüo</strong>sarkoom</td>
</tr>
<tr>
<td><strong>fibro</strong>sarkoom</td>
</tr>
<tr>
<td><strong>sünooviumi</strong> sarkoom</td>
</tr>
<tr>
<td><strong>angio</strong>sarkoom</td>
</tr>
<tr>
<td><strong>kondro</strong>sarkoom</td>
</tr>
</tbody></table>

</div>
  </article>
  <!-- Presenter Notes -->
</slide>

<slide class="" id="slide-18" style="background:;">
  <hgroup>
    <h2>Hematopoieetilised ja lümfoidsed kasvajad</h2>
  </hgroup>
  <article data-timings="">
    <p>Tuumorid mis tekivad <strong>veres, luuüdis ja lümfisõlmedes</strong></p>

<h1>Rakutüübid:</h1>

<ul>
<li><p>Äge ja krooniline müelogeenne leukeemia, müelodüsplastilised sündroomid ja müeloproliferatiivsed haigused: granulotsüüdid, erütrotsüüdid, trombotsüüdid, makrofaagid ja nuumrakud (<em>mast cells</em>)</p></li>
<li><p>Lümfoomid, lümfotsüütsed leukeemiad ja müeloomid: B-, T-, NK- ja plasma rakud</p>

<ul>
<li>äge lümfotsüütne leukeemia (<strong>ALL</strong>) tekib 80% juhtudel B-rakkudest ja 20% T-rakkudest</li>
</ul></li>
</ul>

  </article>
  <!-- Presenter Notes -->
</slide>

<slide class="" id="slide-19" style="background:;">
  <hgroup>
    <h2>Sagedasemad hematopoieetilised kasvajad</h2>
  </hgroup>
  <article data-timings="">
    
<div style='float:left;width:48%;' class='centered'>
  <table><thead>
<tr>
<th></th>
</tr>
</thead><tbody>
<tr>
<td>äge lümfotsüütne leukeemia (<strong>ALL</strong>)</td>
</tr>
<tr>
<td>äge müelogeenne leukeemia (<strong>AML</strong>)</td>
</tr>
<tr>
<td>krooniline müelogeenne leukeemia (<strong>CML</strong>)</td>
</tr>
<tr>
<td>krooniline lümfotsüütne leukeemia (<strong>CLL</strong>)</td>
</tr>
<tr>
<td>multimüeloom (<strong>MM</strong>)</td>
</tr>
<tr>
<td>non-Hodgkin&#39;s lümfoom (<strong>NHL</strong>)</td>
</tr>
<tr>
<td>Hodgkin&#39;s tõbi</td>
</tr>
</tbody></table>

</div>
<div style='float:right;width:48%;'>
  <p><img src="http://www.pathologystudent.com/wp-content/uploads/2009/04/aml-m5b-hi1.jpg" style="width:420px"></p>

<p><footer class="source"><a href="http://www.pathologystudent.com">Pilt: pathologystudent.com</a></footer></p>

</div>
  </article>
  <!-- Presenter Notes -->
</slide>

<slide class="" id="slide-20" style="background:;">
  <hgroup>
    <h2>Translokatsoonid on hematopoieetilistes kasvajates tavalised</h2>
  </hgroup>
  <article data-timings="">
    <p>ALL-i translokatsoonid</p>

<table><thead>
<tr>
<th>Tsütogeneetiline translokatsioon</th>
<th>Molekulaar-geneetiline mutatsioon</th>
<th>%</th>
</tr>
</thead><tbody>
<tr>
<td>krüptiline t(12;21)</td>
<td>TEL-AML1 fuusion</td>
<td>25.4%</td>
</tr>
<tr>
<td>t(1;19)(q23;p13)</td>
<td>E2A-PBX fuusion</td>
<td>4.8%</td>
</tr>
<tr>
<td>t(9;22)(q34;q11)</td>
<td>BCR-ABL fuusion (90% CML juhtudest)</td>
<td>1.6%</td>
</tr>
<tr>
<td>t(4;11)(q21;q23)</td>
<td>MLL-AF4 fuusion</td>
<td>1.6%</td>
</tr>
<tr>
<td>t(8;14)(q24;q32)</td>
<td>IGH-MYC fuusion</td>
<td></td>
</tr>
<tr>
<td>t(11;14)(p13;q11)</td>
<td>TCR-RBTN2 fuusion</td>
<td></td>
</tr>
</tbody></table>

  </article>
  <!-- Presenter Notes -->
</slide>

<slide class="" id="slide-21" style="background:;">
  <hgroup>
    <h2>Neuroektodermaalsed kasvajad</h2>
  </hgroup>
  <article data-timings="">
    <ul>
<li>Vähid mis tekivad <strong>kesknärvisüsteemis ja perifeerses närvisüsteemis</strong></li>
<li><strong>ektodermaalset</strong> päritolu</li>
<li>glioomid, glioblastoomid, neuroblastoomid, shwannoomid/oligodendroglioomid ja medulloblastoomid</li>
<li>moodustavad 1.3% diagnoositud kasvajatest, suremus samas kõrge 2.5% vähisurmadest</li>
</ul>

  </article>
  <!-- Presenter Notes -->
</slide>

<slide class="" id="slide-22" style="background:;">
  <hgroup>
    <h1>CNS/PNS kasvajad</h1>
  </hgroup>
  <article data-timings="">
    
<div style='float:left;width:48%;' class='centered'>
  <ul>
<li>glioblastoomid <strong>GBM</strong> ja astrotsütoomid: astrotsüüdid

<ul>
<li>GBM, agressiivne IV staadiumi astrotsütoom</li>
</ul></li>
<li>shwannoomid/oligodendroglioomid pärinevad müeliini moodustavatest rakkudest</li>
<li>retinoblastoom</li>
<li>neuroblastoomid pärinevad PNSi ganglionitest </li>
</ul>

</div>
<div style='float:right;width:48%;'>
  <p><img src="http://upload.wikimedia.org/wikipedia/commons/f/ff/Glioblastoma_%281%29.jpg" style="width:400px"></p>

<p><footer class="source">Pilt:<a href="http://en.wikipedia.org/wiki/Glioblastoma_multiforme">wikimedia</a></footer></p>

</div>
  </article>
  <!-- Presenter Notes -->
</slide>

<slide class="" id="slide-23" style="background:;">
  <hgroup>
    <h2>Vähid mis ei klassifitseeru epi-mese-neuro järgi</h2>
  </hgroup>
  <article data-timings="">
    <ul>
<li><strong>melanoom</strong></li>
<li><strong>väikeserakulised kopsukasvajad</strong> (<em>SCLC</em>)</li>
</ul>

<p>Naha melanotsüüdid pärinevad neuraalharjast</p>

<p><img src="http://web.biologie.uni-bielefeld.de/cellbiology/images/scientific-schemes/neural%20crest.jpg" style="width:400px"></p>

<p><footer class="source"><a href="http://web.biologie.uni-bielefeld.de/cellbiology/index.php/research/neural-crest-derived-stem-cells">Pilt:web.biologie.uni-bielefeld.de</a></footer></p>

  </article>
  <!-- Presenter Notes -->
</slide>

<slide class="" id="slide-24" style="background:;">
  <hgroup>
    <h2>Melanoom</h2>
  </hgroup>
  <article data-timings="">
    
<div style='float:left;width:48%;' class='centered'>
  <ul>
<li>Eestis 12pt/100tuh</li>
<li>kirurgiline ravi lähtub paksusest (&gt;1 mm), </li>
<li>elulemus on otseselt seotud paksusega</li>
<li>siirded lümfisõlmedes:

<ul>
<li>&gt;4 mm 35%</li>
<li>&lt;1 mm 0.1%</li>
</ul></li>
</ul>

</div>
<div style='float:right;width:48%;'>
  <p><img src="http://www.aocd.org/resource/resmgr/ddb_high/melanoma_2_high.jpg" style="width:400px"></p>

<p><footer class="source"><a href="http://www.aocd.org/?page=Melanoma">Pilt:www.aocd.org</a></footer></p>

</div>
  </article>
  <!-- Presenter Notes -->
</slide>

<slide class="" id="slide-25" style="background:;">
  <hgroup>
    <h2>SCLC</h2>
  </hgroup>
  <article data-timings="">
    <p>Small-cell lung cancer (SCLC) is an exceptionally aggressive disease with poor prognosis</p>

<ul>
<li>10–15% of the new lung cancer cases year</li>
<li>high proliferative index and early metastasis</li>
</ul>

  </article>
  <!-- Presenter Notes -->
</slide>

<slide class="" id="slide-26" style="background:;">
  <hgroup>
    <h2>SCLC</h2>
  </hgroup>
  <article data-timings="">
    <ul>
<li>sarnased <strong>neurosekretoorsetele</strong> rakkudele (nt. neerupealised, ajuripats)

<ul>
<li>sekreteerivad peptiidhormoone nt. adrenokortikotropiin</li>
</ul></li>
<li>arvatavasti siiski kopsu enda endodermaalset päritolu rakud, mis on <strong>transdifferentseerunud</strong></li>
</ul>

  </article>
  <!-- Presenter Notes -->
</slide>

<slide class="" id="slide-27" style="background:;">
  <hgroup>
    <h2>Epiteeli-mesenhümaalne transformatsioon</h2>
  </hgroup>
  <article data-timings="">
    <p><strong>EMT</strong> on raku transdifferentseerumine, kus algne <strong>kartsinoomi rakk omandab mesenhümaalse fenotüübi</strong></p>

<ul>
<li>EMT on seotud metastaseerumisega</li>
<li>NB! EMT ei ole kartsinoomis histoloogiliselt jälgitav</li>
<li>tegemist võib olla transientse seisundiga</li>
</ul>

<p><img src="http://www.sabiosciences.com/images/Fig3_Fibrosis.gif" style="width:300px"></p>

<p><footer class="source">Pilt: <a href="http://www.sabiosciences.com/">http://www.sabiosciences.com/</a></footer></p>

  </article>
  <!-- Presenter Notes -->
</slide>

<slide class="" id="slide-28" style="background:;">
  <hgroup>
    <h2>Reeglina säilitavad vähid oma päritolu-koe tunnused</h2>
  </hgroup>
  <article data-timings="">
    <p>Olulise ühendva bioloogilise printsiibina säilitavad vähirakud alati mõne distinktse diferentseerunud tunnuse mis seob neid oma päritolukoega</p>

<p><img src="http://www.breastpathology.info/Images/LVi%20&amp;%20nodes/micromet-pan-ck.jpg" alt="kermets"></p>

<p><footer class="source">Pilt: tsütokeratiin-positiivne mikrometastaas. <a href="http://www.breastpathology.info">www.breastpathology.info</a></footer></p>

  </article>
  <!-- Presenter Notes -->
</slide>

<slide class="" id="slide-29" style="background:;">
  <hgroup>
    <h2>Anaplastilised kasvajad</h2>
  </hgroup>
  <article data-timings="">
    <p><strong>Anaplaasia</strong> - kasvaja mis on kaotanud koespetsiifilised tunnused (1-2% juhtudest)</p>

<ul>
<li><strong>histopatoloogliselt pole võimalik identifitseerda päritolu-kude</strong></li>
<li>võib tekkida dediferentseerumise teel</li>
<li>võib pärineda tüvirakkudest</li>
<li><strong>pleomorfism</strong>, rakud ja tuumad on ebaühtlase suuruse-kujuga</li>
</ul>

<p><img src="http://upload.wikimedia.org/wikipedia/commons/thumb/8/83/Serous_carcinoma_2a_-_cytology.jpg/300px-Serous_carcinoma_2a_-_cytology.jpg" alt="anaplaasia"></p>

  </article>
  <!-- Presenter Notes -->
</slide>

<slide class="" id="slide-30" style="background:;">
  <hgroup>
    <h2>Molekulaarne klassifikatsioon</h2>
  </hgroup>
  <article data-timings="">
    
<div style='float:left;width:48%;' class='centered'>
  <ul>
<li>osad kasvajad koespetsiifilised, teised mitte:</li>
<li>kopsu lamerakk, pea-kaela ja osa põiekasvajaid moodustavad ühe alatüübi</li>
<li>põievähid lahknevad eri alatüüpidesse.</li>
</ul>

</div>
<div style='float:right;width:48%;'>
  <p><img src="http://www.cell.com/cms/attachment/2035837326/2051298972/fx1.jpg" alt="MolClassification"></p>

<p><footer class="source"><a href="http://www.sciencedirect.com/science/article/pii/S0092867414008769">Multiplatform Analysis of 12 Cancer Types Reveals Molecular Classification within and across Tissues of Origin</a></footer></p>

</div>
  </article>
  <!-- Presenter Notes -->
</slide>

<slide class="" id="slide-31" style="background:;">
  <hgroup>
    <h2>Vähid arenevad progresseeruvalt</h2>
  </hgroup>
  <article data-timings="">
    
<div style='float:left;width:48%;' class='centered'>
  <p>Vähi staadiume iseloomustab järk-järguline progresseerumine healoomulisest kasvajast kuni metastaasideni</p>

</div>
<div style='float:right;width:48%;'>
  <p><img src="http://www.hopkinscoloncancercenter.org/Upload/200812051423_11416_000.jpg" alt="progressioon"></p>

<p><footer class="source"><a href="http://www.hopkinscoloncancercenter.org/CMS/CMS_Page.aspx?CurrentUDV=59&amp;CMS_Page_ID=0B34E9BE-5DE6-4CB4-B387-4158CC924084">Pilt:hopkinscoloncancercenter.org</a></footer></p>

</div>
  </article>
  <!-- Presenter Notes -->
</slide>

<slide class="" id="slide-32" style="background:;">
  <hgroup>
    <h2>Kasvaja kliiniline progressioon</h2>
  </hgroup>
  <article data-timings="">
    <p><strong>Neoplaasiad</strong> - eri tüüpi kasvajalised moodustised</p>

<p>Rohkem-vähem defineeritud &quot;peatused&quot; kasvaja arengus:</p>

<p>Normaalne kude &gt; hüper-/metaplastiline &gt; düsplaasia &gt; lokaalselt invasiivne &gt; metastaasid</p>

  </article>
  <!-- Presenter Notes -->
</slide>

<slide class="" id="slide-33" style="background:;">
  <hgroup>
    <h2>Healoomulised kasvajad</h2>
  </hgroup>
  <article data-timings="">
    <p>Healoomulised (<em>benign</em>) kasvajad võivad olla <strong>hüperplastilised</strong> või <strong>metaplastilised</strong> (<em>hyperplastic</em>, <em>metaplastic</em>)</p>

<ul>
<li>hüperplastiline kude näeb välja normaalsena, välja arvatud märgatavalt suurenenud rakkude arv</li>
<li>metaplastilises koes on üks normaalne kude asendunud teisega nt. Barreti söögitoru</li>
</ul>

<p><img src="http://upload.wikimedia.org/wikipedia/commons/thumb/8/86/Barretts_esophagus.jpg/345px-Barretts_esophagus.jpg" alt="metaplaasia"></p>

  </article>
  <!-- Presenter Notes -->
</slide>

<slide class="" id="slide-34" style="background:;">
  <hgroup>
    <h2>Düsplaasia</h2>
  </hgroup>
  <article data-timings="">
    
<div style='float:left;width:48%;' class='centered'>
  <p><img src="http://upload.wikimedia.org/wikipedia/commons/thumb/a/a7/Verruca_vulgaris_-_very_low_mag.jpg/330px-Verruca_vulgaris_-_very_low_mag.jpg" alt="wart"></p>

</div>
<div style='float:right;width:48%;'>
  <p><strong>Düsplaasiad</strong> sisaldavad juba rakke mis näevad välja ebanormaalsed.</p>

<ul>
<li>healoomulised kuid pre-maliigne seisund (basaalmembraan on terve!)</li>
<li>adenoomid, polüübid, papilloomid, soolatüükad</li>
</ul>

</div>
  </article>
  <!-- Presenter Notes -->
</slide>

<slide class="" id="slide-35" style="background:;">
  <hgroup>
    <h2>Pahaloomulised kasvajad</h2>
  </hgroup>
  <article data-timings="">
    
<div style='float:left;width:48%;' class='centered'>
  <p>iseloomustab invasiivsus st. vähirakud on tunginud läbi <strong>basaalmembraani</strong></p>

<ul>
<li>lokaalselt invasiivne</li>
<li>siirded</li>
</ul>

</div>
<div style='float:right;width:48%;'>
  <p><img src="http://cshperspectives.cshlp.org/content/3/12/a005058/F5.medium.gif" alt="BM"></p>

</div>
  </article>
  <!-- Presenter Notes -->
</slide>

<slide class="" id="slide-36" style="background:;">
  <hgroup>
    <h2>Metastaasid e. siirded</h2>
  </hgroup>
  <article data-timings="">
    <p>Kasvajakolooniate teke keha teistesse osadesse/organitesse</p>

<ul>
<li>lisaks invasiivsusele peab vähirakk omandama ka <strong>amööbse liikumise võime</strong> (<em>motility</em>)</li>
<li>ja <strong>võime adapteeruda</strong> &quot;võõras keskkonnas&quot;</li>
</ul>

  </article>
  <!-- Presenter Notes -->
</slide>

<slide class="" id="slide-37" style="background:;">
  <hgroup>
    <h2>Kasvajad on monoklonaalsed</h2>
  </hgroup>
  <article data-timings="">
    <p>Teoreetiliselt võivad kasvajat moodustavad vähirakud  olla pärit</p>

<ul>
<li><strong>monoklonaalselt</strong> </li>
<li><strong>polüklonaalselt</strong> </li>
</ul>

  </article>
  <!-- Presenter Notes -->
</slide>

<slide class="" id="slide-38" style="background:;">
  <hgroup>
    <h2>Kasvaja klonaalsus</h2>
  </hgroup>
  <article data-timings="">
    <p>Epigeneetika viitab monoklonaalsele päritolule</p>

<p>R. Weinberg et al. analüüsisid leiomüoome, 1965. a </p>

<ul>
<li>X-kromosoomi inaktivatsioon on juhuslik</li>
<li>30% Aafrika päritolu naistel on polümorfsm G6PD geenis (asub X-is)</li>
<li>heterosügootide analüüsil leiti, et igal leiomüoomil esines ainult ühte geeni versiooni</li>
</ul>

  </article>
  <!-- Presenter Notes -->
</slide>

<slide class="" id="slide-39" style="background:;">
  <hgroup>
    <h2>Kasvaja klonaalsus - müeloomid</h2>
  </hgroup>
  <article data-timings="">
    <ul>
<li>müeloomid pärinevad B-rakkude eellastest, antikehi tootvatest plasmarakkudest</li>
<li>iga antikeha toodab üks kloon</li>
<li>igal patsiendil toodab müeloom vaid ühte antikeha</li>
</ul>

  </article>
  <!-- Presenter Notes -->
</slide>

<slide class="" id="slide-40" style="background:;">
  <hgroup>
    <h2>Kasvaja evolutsioon: Clonal expansions</h2>
  </hgroup>
  <article data-timings="">
    <ul>
<li><strong>Common feature of neoplastic progression is the expansion of a clone with a genetic or epigenetic alteration.</strong></li>
<li>This may be a matter of chance, but is more likely due to the expanding clone having a competitive advantage</li>
<li>Clonal expansions are most often associated with the loss of the p53 (TP53) or p16 (CDKN2A/INK4a) tumor suppressor genes</li>
<li>process of developing cancer involves successive waves of clonal expansions within the tumor</li>
</ul>

  </article>
  <!-- Presenter Notes -->
</slide>

<slide class="" id="slide-41" style="background:;">
  <hgroup>
    <h2>Countries showing highest and lowest incidence of specific types of cancer</h2>
  </hgroup>
  <article data-timings="">
    <table><thead>
<tr>
<th>Cancer site</th>
<th>Country of highest risk</th>
<th>Country of lowest risk</th>
<th>Relative risk H/L</th>
</tr>
</thead><tbody>
<tr>
<td>Melanoma</td>
<td>Australia (Queensland)</td>
<td>Japan</td>
<td>155</td>
</tr>
<tr>
<td>Lip</td>
<td>Canada (Newfoundland)</td>
<td>Japan</td>
<td>151</td>
</tr>
<tr>
<td>Nasopharynx</td>
<td>Hong Kong</td>
<td>United Kingdom</td>
<td>100</td>
</tr>
<tr>
<td>Prostate</td>
<td>U.S. (African American)</td>
<td>China</td>
<td>70</td>
</tr>
<tr>
<td>Liver</td>
<td>China (Shanghai)</td>
<td>Canada (Nova Scotia)</td>
<td>49</td>
</tr>
<tr>
<td>Penis</td>
<td>Brazil</td>
<td>Israel (Ashkenazic)</td>
<td>42</td>
</tr>
<tr>
<td>Cervix (uterus)</td>
<td>Brazil Israel (non-Jews)</td>
<td>28</td>
<td></td>
</tr>
<tr>
<td>Stomach</td>
<td>Japan</td>
<td>Kuwait</td>
<td>22</td>
</tr>
<tr>
<td>Lung</td>
<td>U.S. (Louisiana, African American)</td>
<td>India (Madras)</td>
<td>19</td>
</tr>
<tr>
<td>Pancreas</td>
<td>U.S. (Los Angeles, Korean American)</td>
<td>India</td>
<td>11</td>
</tr>
<tr>
<td>Ovary</td>
<td>New Zealand (Polynesian)</td>
<td>Kuwait</td>
<td>8</td>
</tr>
</tbody></table>

  </article>
  <!-- Presenter Notes -->
</slide>

<slide class="" id="slide-42" style="background:;">
  <hgroup>
    <h2>Kasvajarisk on seotud elustiiliga</h2>
  </hgroup>
  <article data-timings="">
    <p><strong>Suitsetamine: 96% kopsuvähkidest tekib suitsetajatel</strong></p>

<table><thead>
<tr>
<th>Sigarette päevas enne haigestumist</th>
<th>Suheline risk</th>
</tr>
</thead><tbody>
<tr>
<td>mittesuitsetaja</td>
<td>1</td>
</tr>
<tr>
<td>1 kuni 5</td>
<td>8</td>
</tr>
<tr>
<td>5 kuni 15</td>
<td>12</td>
</tr>
<tr>
<td>15 kuni 25</td>
<td>14</td>
</tr>
<tr>
<td>25+</td>
<td>27</td>
</tr>
</tbody></table>

  </article>
  <!-- Presenter Notes -->
</slide>

<slide class="" id="slide-43" style="background:;">
  <hgroup>
    <h2>Keskkonna ja elustiilifaktorid</h2>
  </hgroup>
  <article data-timings="">
    <table><thead>
<tr>
<th>Type</th>
<th>% of total cases</th>
</tr>
</thead><tbody>
<tr>
<td><strong>Cancers due to occupational exposures</strong></td>
<td>1–2</td>
</tr>
<tr>
<td><strong>Lifestyle cancers</strong></td>
<td></td>
</tr>
<tr>
<td>Tobacco-related (sites: e.g., lung, bladder, kidney)</td>
<td>34</td>
</tr>
<tr>
<td>Diet (low in vegetables, high in nitrates, salt) (sites: e.g., stomach, esophagus)</td>
<td>5</td>
</tr>
<tr>
<td>Diet (high fat, lower fiber, broiled/fried foods) (sites: e.g., bowel, pancreas, prostate, breast)</td>
<td>37</td>
</tr>
<tr>
<td>Tobacco and alcohol (sites: mouth, throat)</td>
<td>2</td>
</tr>
</tbody></table>

  </article>
  <!-- Presenter Notes -->
</slide>

<slide class="" id="slide-44" style="background:;">
  <hgroup>
    <h2>Kartsinogeenina toimivad nii füüsilised kui keemised mutageenid</h2>
  </hgroup>
  <article data-timings="">
    <ul>
<li><strong>röntgenkiired</strong></li>
<li><strong>benseen</strong> (ägedad leukeemiad)</li>
<li><strong>vinüülkloriid</strong> (maksa angiosarkoom)</li>
<li><strong>raadium</strong>(osteosarkoom)</li>
<li><strong>asbest</strong> (mesotelioom)</li>
<li><strong>põsetubakas</strong> (suuõõne kartsinoom)</li>
<li>etc. etc</li>
</ul>

  </article>
  <!-- Presenter Notes -->
</slide>

<slide class="" id="slide-45" style="background:;">
  <hgroup>
    <h2>Mutageesuse test: Amesi test</h2>
  </hgroup>
  <article data-timings="">
    <p><strong>Mutageensus korreleerub kantserogeensusega! Kuid kõik kantserogeenid ei ole mutageenid, selliseid nimetatake kasvaja promootoriteks</strong> </p>

<ul>
<li>Uuritav aine aktiveeritakse metabooselt kasutades roti maksa ekstrakti</li>
<li>aktiveeritud aine lisatakse his-mutantsetele <em>Salmonella</em> tassidele</li>
<li>algne <em>Salmonella</em> mutant ei suuda kasvada söömel milles puudub histidiin </li>
<li>katse lõpus loetakse kolooniad üle</li>
<li>mida rohkem kolooniad seda tugevam mutageen</li>
</ul>

  </article>
  <!-- Presenter Notes -->
</slide>

<slide class="" id="slide-46" style="background:;">
  <hgroup>
    <h2>Bruce Ames&#39;s carcinogens identified in the normal diet</h2>
  </hgroup>
  <article data-timings="">
    <table><thead>
<tr>
<th>Foodstuff</th>
<th>Compound</th>
<th>Concentration in foodstuff</th>
</tr>
</thead><tbody>
<tr>
<td>Black pepper</td>
<td>piperine</td>
<td>100 mg/g</td>
</tr>
<tr>
<td>Common mushroom</td>
<td>agaritine</td>
<td>3 mg/g</td>
</tr>
<tr>
<td>Celery</td>
<td>furocoumarins, psoralens</td>
<td>1 mg/g, 0.8 mg/g</td>
</tr>
<tr>
<td>Rhubarb</td>
<td>anthraquinones</td>
<td>varies</td>
</tr>
<tr>
<td>Cocoa powder</td>
<td>theobromine</td>
<td>20 mg/g</td>
</tr>
<tr>
<td>Mustard, horseradish</td>
<td>allyl isothiocyanate</td>
<td>varies</td>
</tr>
<tr>
<td>Alfalfa sprouts</td>
<td>canavaninec</td>
<td>15 mg/g</td>
</tr>
<tr>
<td>Burnt materialsd</td>
<td>large number</td>
<td>varies</td>
</tr>
<tr>
<td>Coffee</td>
<td>caffeic acid</td>
<td>11.6 mg/g</td>
</tr>
</tbody></table>

  </article>
  <!-- Presenter Notes -->
</slide>

<slide class="" id="slide-47" style="background:;">
  <hgroup>
    <h2>Significant portion of human cancers is attributable directly to the consumption of foodstuffs</h2>
  </hgroup>
  <article data-timings="">
    <p>The Ames test combined with other discoveries led to the model, still
unproven, that a significant portion of human cancers is attributable directly
to the consumption of foodstuffs that are mutagenic and hence carcinogenic.</p>

  </article>
  <!-- Presenter Notes -->
</slide>

<slide class="" id="slide-48" style="background:;">
  <hgroup>
    <h2>Lingid loengutele</h2>
  </hgroup>
  <article data-timings="">
    
<div style='float:left;width:48%;' class='centered'>
  <ul>
<li><a href="http://tpall.github.io/sissejuhatus">Sissejuhatav loeng</a></li>
<li><a href="http://rpubs.com/tapa741/vahityybid">Vähitüübid</a></li>
<li><a href="http://tpall.github.io/Onkoviirused">Onkoviirused</a></li>
<li><a href="http://tpall.github.io/Onkogeenid">Onkogeenid</a></li>
<li><a href="http://tpall.github.io/Retseptorid">Retseptorid</a></li>
<li><a href="http://tpall.github.io/Signaalirajad">Signaalirajad</a></li>
<li><a href="http://tpall.github.io/Tuumorsupressorid">Tuumorsupressorgeenid</a></li>
<li><a href="http://tpall.github.io/Rakutsyklikontroll">Rakutsüklikontroll</a></li>
</ul>

</div>
<div style='float:right;width:48%;'>
  <ul>
<li><a href="http://tpall.github.io/p53-ja-apoptoos">p53 ja apoptoos</a></li>
<li><a href="http://tpall.github.io/Immortalisatsioon">Immortalisatsioon</a></li>
<li><a href="http://tpall.github.io/Tumorigenees">Tumorigenees</a></li>
<li><a href="http://tpall.github.io/Genoomiterviklikkus">Genoomiterviklikkus</a></li>
<li><a href="http://tpall.github.io/Mikrokeskkond">Mikrokeskkond</a></li>
<li><a href="http://tpall.github.io/Metastaas">Metastaasid</a></li>
<li><a href="http://tpall.github.io/Immuunsus">Immuunsus</a></li>
<li><a href="http://tpall.github.io/Vahiravim">Vähiravimid</a></li>
</ul>

</div>
  </article>
  <!-- Presenter Notes -->
</slide>

    <slide class="backdrop"></slide>
  </slides>
  <div class="pagination pagination-small" id='io2012-ptoc' style="display:none;">
    <ul>
      <li>
      <a href="#" target="_self" rel='tooltip' 
        data-slide=1 title='NA'>
         1
      </a>
    </li>
    <li>
      <a href="#" target="_self" rel='tooltip' 
        data-slide=2 title='Ajaloost'>
         2
      </a>
    </li>
    <li>
      <a href="#" target="_self" rel='tooltip' 
        data-slide=3 title='Egiptus, 16-17. dünastia'>
         3
      </a>
    </li>
    <li>
      <a href="#" target="_self" rel='tooltip' 
        data-slide=4 title='Kasvajad kui tulnukad'>
         4
      </a>
    </li>
    <li>
      <a href="#" target="_self" rel='tooltip' 
        data-slide=5 title='Kasvajad on koelise struktuuriga'>
         5
      </a>
    </li>
    <li>
      <a href="#" target="_self" rel='tooltip' 
        data-slide=6 title='Vähki põhjustavad kartsinogeenid'>
         6
      </a>
    </li>
    <li>
      <a href="#" target="_self" rel='tooltip' 
        data-slide=7 title='Vähitüübid'>
         7
      </a>
    </li>
    <li>
      <a href="#" target="_self" rel='tooltip' 
        data-slide=8 title='Kliiniline klassifikatsioon'>
         8
      </a>
    </li>
    <li>
      <a href="#" target="_self" rel='tooltip' 
        data-slide=9 title='Neli põhilist vähitüüpi'>
         9
      </a>
    </li>
    <li>
      <a href="#" target="_self" rel='tooltip' 
        data-slide=10 title='Epiteel'>
         10
      </a>
    </li>
    <li>
      <a href="#" target="_self" rel='tooltip' 
        data-slide=11 title='Basaalmembraan'>
         11
      </a>
    </li>
    <li>
      <a href="#" target="_self" rel='tooltip' 
        data-slide=12 title='Kartsinoomid'>
         12
      </a>
    </li>
    <li>
      <a href="#" target="_self" rel='tooltip' 
        data-slide=13 title='Epiteelid pärinevad erinevatest lootelehtedest'>
         13
      </a>
    </li>
    <li>
      <a href="#" target="_self" rel='tooltip' 
        data-slide=14 title='Kartsinoomid jagunevad laias laastus kaheks'>
         14
      </a>
    </li>
    <li>
      <a href="#" target="_self" rel='tooltip' 
        data-slide=15 title='Kartsinoomide sagedasemad paikmed'>
         15
      </a>
    </li>
    <li>
      <a href="#" target="_self" rel='tooltip' 
        data-slide=16 title='Mitte-epiteliaalsed kasvajad'>
         16
      </a>
    </li>
    <li>
      <a href="#" target="_self" rel='tooltip' 
        data-slide=17 title='Sarkoomid'>
         17
      </a>
    </li>
    <li>
      <a href="#" target="_self" rel='tooltip' 
        data-slide=18 title='Hematopoieetilised ja lümfoidsed kasvajad'>
         18
      </a>
    </li>
    <li>
      <a href="#" target="_self" rel='tooltip' 
        data-slide=19 title='Sagedasemad hematopoieetilised kasvajad'>
         19
      </a>
    </li>
    <li>
      <a href="#" target="_self" rel='tooltip' 
        data-slide=20 title='Translokatsoonid on hematopoieetilistes kasvajates tavalised'>
         20
      </a>
    </li>
    <li>
      <a href="#" target="_self" rel='tooltip' 
        data-slide=21 title='Neuroektodermaalsed kasvajad'>
         21
      </a>
    </li>
    <li>
      <a href="#" target="_self" rel='tooltip' 
        data-slide=22 title='CNS/PNS kasvajad'>
         22
      </a>
    </li>
    <li>
      <a href="#" target="_self" rel='tooltip' 
        data-slide=23 title='Vähid mis ei klassifitseeru epi-mese-neuro järgi'>
         23
      </a>
    </li>
    <li>
      <a href="#" target="_self" rel='tooltip' 
        data-slide=24 title='Melanoom'>
         24
      </a>
    </li>
    <li>
      <a href="#" target="_self" rel='tooltip' 
        data-slide=25 title='SCLC'>
         25
      </a>
    </li>
    <li>
      <a href="#" target="_self" rel='tooltip' 
        data-slide=26 title='SCLC'>
         26
      </a>
    </li>
    <li>
      <a href="#" target="_self" rel='tooltip' 
        data-slide=27 title='Epiteeli-mesenhümaalne transformatsioon'>
         27
      </a>
    </li>
    <li>
      <a href="#" target="_self" rel='tooltip' 
        data-slide=28 title='Reeglina säilitavad vähid oma päritolu-koe tunnused'>
         28
      </a>
    </li>
    <li>
      <a href="#" target="_self" rel='tooltip' 
        data-slide=29 title='Anaplastilised kasvajad'>
         29
      </a>
    </li>
    <li>
      <a href="#" target="_self" rel='tooltip' 
        data-slide=30 title='Molekulaarne klassifikatsioon'>
         30
      </a>
    </li>
    <li>
      <a href="#" target="_self" rel='tooltip' 
        data-slide=31 title='Vähid arenevad progresseeruvalt'>
         31
      </a>
    </li>
    <li>
      <a href="#" target="_self" rel='tooltip' 
        data-slide=32 title='Kasvaja kliiniline progressioon'>
         32
      </a>
    </li>
    <li>
      <a href="#" target="_self" rel='tooltip' 
        data-slide=33 title='Healoomulised kasvajad'>
         33
      </a>
    </li>
    <li>
      <a href="#" target="_self" rel='tooltip' 
        data-slide=34 title='Düsplaasia'>
         34
      </a>
    </li>
    <li>
      <a href="#" target="_self" rel='tooltip' 
        data-slide=35 title='Pahaloomulised kasvajad'>
         35
      </a>
    </li>
    <li>
      <a href="#" target="_self" rel='tooltip' 
        data-slide=36 title='Metastaasid e. siirded'>
         36
      </a>
    </li>
    <li>
      <a href="#" target="_self" rel='tooltip' 
        data-slide=37 title='Kasvajad on monoklonaalsed'>
         37
      </a>
    </li>
    <li>
      <a href="#" target="_self" rel='tooltip' 
        data-slide=38 title='Kasvaja klonaalsus'>
         38
      </a>
    </li>
    <li>
      <a href="#" target="_self" rel='tooltip' 
        data-slide=39 title='Kasvaja klonaalsus - müeloomid'>
         39
      </a>
    </li>
    <li>
      <a href="#" target="_self" rel='tooltip' 
        data-slide=40 title='Kasvaja evolutsioon: Clonal expansions'>
         40
      </a>
    </li>
    <li>
      <a href="#" target="_self" rel='tooltip' 
        data-slide=41 title='Countries showing highest and lowest incidence of specific types of cancer'>
         41
      </a>
    </li>
    <li>
      <a href="#" target="_self" rel='tooltip' 
        data-slide=42 title='Kasvajarisk on seotud elustiiliga'>
         42
      </a>
    </li>
    <li>
      <a href="#" target="_self" rel='tooltip' 
        data-slide=43 title='Keskkonna ja elustiilifaktorid'>
         43
      </a>
    </li>
    <li>
      <a href="#" target="_self" rel='tooltip' 
        data-slide=44 title='Kartsinogeenina toimivad nii füüsilised kui keemised mutageenid'>
         44
      </a>
    </li>
    <li>
      <a href="#" target="_self" rel='tooltip' 
        data-slide=45 title='Mutageesuse test: Amesi test'>
         45
      </a>
    </li>
    <li>
      <a href="#" target="_self" rel='tooltip' 
        data-slide=46 title='Bruce Ames&#39;s carcinogens identified in the normal diet'>
         46
      </a>
    </li>
    <li>
      <a href="#" target="_self" rel='tooltip' 
        data-slide=47 title='Significant portion of human cancers is attributable directly to the consumption of foodstuffs'>
         47
      </a>
    </li>
    <li>
      <a href="#" target="_self" rel='tooltip' 
        data-slide=48 title='Lingid loengutele'>
         48
      </a>
    </li>
  </ul>
  </div>  <!--[if IE]>
    <script 
      src="http://ajax.googleapis.com/ajax/libs/chrome-frame/1/CFInstall.min.js">  
    </script>
    <script>CFInstall.check({mode: 'overlay'});</script>
  <![endif]-->
</body>
  <!-- Load Javascripts for Widgets -->
  
  <!-- LOAD HIGHLIGHTER JS FILES -->
  <script src="libraries/highlighters/highlight.js/highlight.pack.js"></script>
  <script>hljs.initHighlightingOnLoad();</script>
  <!-- DONE LOADING HIGHLIGHTER JS FILES -->
   
  </html>